SNAREBIA Trademark

Trademark Overview


On Thursday, March 19, 2015, a trademark application was filed for SNAREBIA with the United States Patent and Trademark Office. The USPTO has given the SNAREBIA trademark a serial number of 79167212. The federal status of this trademark filing is CANCELLED - SECTION 71 as of Friday, July 29, 2022. This trademark is owned by DAIICHI SANKYO COMPANY, LIMITED. The SNAREBIA trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the treatment and prevention of cardiovascular disease, sclerosis, atherosclerosis, diabetic nephropathy, stroke, heart attack, hypercholesterolemia, dyslipidemia, anemia, blood disorders, diabetes, thyroid function disease, cancer, oncological disease, leukemia, metastasis, autoimmune disease, rheumatoid arthritis, allergy, bacterial infection, viral infection, fungal infection, inflammation, sepsis, spinal cord injury, musculoskeletal disorders, pain, central nervous system disease, neurological disease, mood disorders, osteoporosis, Alzheimer's disease, obesity, anorexia, urinary and kidney disease, respiratory disease, gastrointestinal disease, constipation; vaccines; diagnostic reagents and contrast media for medical use
snarebia

General Information


Serial Number79167212
Word MarkSNAREBIA
Filing DateThursday, March 19, 2015
Status709 - CANCELLED - SECTION 71
Status DateFriday, July 29, 2022
Registration Number4883688
Registration DateTuesday, January 12, 2016
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, October 27, 2015

Trademark Statements


Goods and ServicesPharmaceutical preparations for the treatment and prevention of cardiovascular disease, sclerosis, atherosclerosis, diabetic nephropathy, stroke, heart attack, hypercholesterolemia, dyslipidemia, anemia, blood disorders, diabetes, thyroid function disease, cancer, oncological disease, leukemia, metastasis, autoimmune disease, rheumatoid arthritis, allergy, bacterial infection, viral infection, fungal infection, inflammation, sepsis, spinal cord injury, musculoskeletal disorders, pain, central nervous system disease, neurological disease, mood disorders, osteoporosis, Alzheimer's disease, obesity, anorexia, urinary and kidney disease, respiratory disease, gastrointestinal disease, constipation; vaccines; diagnostic reagents and contrast media for medical use

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status CodeF - NOT AVAILABLE
Class Status DateFriday, July 29, 2022
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameDAIICHI SANKYO COMPANY, LIMITED
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressJP

Party NameDAIICHI SANKYO COMPANY, LIMITED
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressJP

Party NameDAIICHI SANKYO COMPANY, LIMITED
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressJP

Trademark Events


Event DateEvent Description
Monday, May 22, 2023TOTAL INVALIDATION PROCESSED BY THE IB
Tuesday, May 2, 2023TOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB
Tuesday, May 2, 2023INVALIDATION PROCESSED
Wednesday, March 29, 2023TOTAL INVALIDATION OF REG EXT PROTECTION CREATED
Friday, July 29, 2022CANCELLED SECTION 71
Sunday, July 3, 2022NEW REPRESENTATIVE AT IB RECEIVED
Tuesday, January 12, 2021COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
Friday, May 6, 2016FINAL DECISION TRANSACTION PROCESSED BY IB
Friday, April 15, 2016FINAL DISPOSITION NOTICE SENT TO IB
Friday, April 15, 2016FINAL DISPOSITION PROCESSED
Tuesday, April 12, 2016FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Tuesday, January 12, 2016REGISTERED-PRINCIPAL REGISTER
Tuesday, October 27, 2015OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, October 27, 2015PUBLISHED FOR OPPOSITION
Wednesday, October 7, 2015NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Monday, September 21, 2015LAW OFFICE PUBLICATION REVIEW COMPLETED
Tuesday, September 15, 2015APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, July 30, 2015TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, July 30, 2015CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, July 23, 2015ASSIGNED TO LIE
Saturday, July 18, 2015REFUSAL PROCESSED BY IB
Wednesday, July 15, 2015TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, June 30, 2015APPLICATION FILING RECEIPT MAILED
Monday, June 29, 2015NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Monday, June 29, 2015REFUSAL PROCESSED BY MPU
Sunday, June 28, 2015NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Saturday, June 27, 2015NON-FINAL ACTION WRITTEN
Wednesday, June 24, 2015ASSIGNED TO EXAMINER
Wednesday, June 24, 2015NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, June 19, 2015LIMITATION FROM ORIGINAL APPLICATION ENTERED
Thursday, June 18, 2015SN ASSIGNED FOR SECT 66A APPL FROM IB